140 related articles for article (PubMed ID: 38676623)
1. Perispinal Etanercept to improve STroke Outcomes (PESTO): Protocol for a multicenter, international, randomized placebo-controlled trial.
Thijs V; Cloud GC; Gilchrist N; Parsons B; Tilvawala F; Ho J; Ruthnam L; Stanislaus V; Sprigg N; Walker M; Bath PM; Churilov L; Bernhardt J
Eur Stroke J; 2024 Apr; ():23969873241249248. PubMed ID: 38676623
[TBL] [Abstract][Full Text] [Related]
2. Phase I/II parallel double-blind randomized controlled clinical trial of perispinal etanercept for chronic stroke: improved mobility and pain alleviation.
Ralph SJ; Weissenberger A; Bonev V; King LD; Bonham MD; Ferguson S; Smith AD; Goodman-Jones AA; Espinet AJ
Expert Opin Investig Drugs; 2020 Mar; 29(3):311-326. PubMed ID: 31899977
[No Abstract] [Full Text] [Related]
3. Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.
Tobinick E; Kim NM; Reyzin G; Rodriguez-Romanacce H; DePuy V
CNS Drugs; 2012 Dec; 26(12):1051-70. PubMed ID: 23100196
[TBL] [Abstract][Full Text] [Related]
4. Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.
Tobinick E
CNS Drugs; 2011 Feb; 25(2):145-55. PubMed ID: 21254790
[TBL] [Abstract][Full Text] [Related]
5. Rapid improvement in severe long COVID following perispinal etanercept.
Tobinick E; Spengler RN; Ignatowski TA; Wassel M; Laborde S
Curr Med Res Opin; 2022 Dec; 38(12):2013-2020. PubMed ID: 35791687
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial validating the use of perispinal etanercept to reduce post-stroke disability has wide-ranging implications.
Clark IA
Expert Rev Neurother; 2020 Mar; 20(3):203-205. PubMed ID: 32028804
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Anti-TNF agents for paediatric psoriasis.
Sanclemente G; Murphy R; Contreras J; GarcÃa H; Bonfill Cosp X
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010017. PubMed ID: 26598969
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients.
Tobinick E; Davoodifar S
Curr Med Res Opin; 2004 Jul; 20(7):1075-85. PubMed ID: 15265252
[TBL] [Abstract][Full Text] [Related]
11. Central delivery of iodine-125-labeled cetuximab, etanercept and anakinra after perispinal injection in rats: possible implications for treating Alzheimer's disease.
Roerink ME; Groen RJ; Franssen G; Lemmers-van de Weem B; Boerman OC; van der Meer JW
Alzheimers Res Ther; 2015 Nov; 7(1):70. PubMed ID: 26560086
[TBL] [Abstract][Full Text] [Related]
12. Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease.
Tobinick EL; Gross H
BMC Neurol; 2008 Jul; 8():27. PubMed ID: 18644112
[TBL] [Abstract][Full Text] [Related]
13. Perispinal etanercept for treatment of Alzheimer's disease.
Tobinick E
Curr Alzheimer Res; 2007 Dec; 4(5):550-2. PubMed ID: 18220520
[TBL] [Abstract][Full Text] [Related]
14. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
[TBL] [Abstract][Full Text] [Related]
15. Etanercept and efalizumab for the treatment of psoriasis: a systematic review.
Woolacott N; Hawkins N; Mason A; Kainth A; Khadjesari Z; Vergel YB; Misso K; Light K; Chalmers R; Sculpher M; Riemsma R
Health Technol Assess; 2006 Nov; 10(46):1-233, i-iv. PubMed ID: 17083854
[TBL] [Abstract][Full Text] [Related]
16. Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.
Ignatowski TA; Spengler RN; Dhandapani KM; Folkersma H; Butterworth RF; Tobinick E
CNS Drugs; 2014 Aug; 28(8):679-97. PubMed ID: 24861337
[TBL] [Abstract][Full Text] [Related]
17. Perispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanism.
Tobinick E
Medscape J Med; 2008 Jun; 10(6):135. PubMed ID: 18679537
[TBL] [Abstract][Full Text] [Related]
18. Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
van Herwaarden N; den Broeder AA; Jacobs W; van der Maas A; Bijlsma JW; van Vollenhoven RF; van den Bemt BJ
Cochrane Database Syst Rev; 2014 Sep; (9):CD010455. PubMed ID: 25264908
[TBL] [Abstract][Full Text] [Related]
19. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.
Brandt J; Khariouzov A; Listing J; Haibel H; Sörensen H; Grassnickel L; Rudwaleit M; Sieper J; Braun J
Arthritis Rheum; 2003 Jun; 48(6):1667-75. PubMed ID: 12794835
[TBL] [Abstract][Full Text] [Related]
20. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev; ; . PubMed ID: 33871055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
